Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) carries poor survival outcomes despite recent progress in cancer treatment in general. Angiogenesis is crucial for tumour survival and progression. Therefore, several agents targeting the pathways that mediate angiogenesis have been developed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Hyytiäinen, Aini, Wahbi, Wafa, Väyrynen, Otto, Saarilahti, Kauko, Karihtala, Peeter, Salo, Tuula, Al-Samadi, Ahmed
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8236814/
https://ncbi.nlm.nih.gov/pubmed/34195084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.683570
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars